Trevi Therapeutics, Inc.(TRVI)
$11.94▲0.36 (3.11%)
Trevi Therapeutics, Inc.(TRVI)
NASDAQ
$11.94▲0.36 (3.11%)
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-0.29
Operating CF/Share$-0.29
Free CF/Share$-0.20
Cash/Share$1.29
Book Value/Share$1.26
Tangible Book/Share$1.26
Equity/Share$1.26
Interest Debt/Share$0.01
CapEx/Share$0.09
Dividend/Share$0.00
Valuation
Market Cap$1.53B
Enterprise Value$1.51B
P/E Ratio-40.63P/S Ratio0.00P/OCF Ratio-41.28
P/FCF Ratio-53.56
P/B Ratio9.48P/TB Ratio9.48
EV/Sales0.00EV/EBITDA-33.99
Graham Valuation
Graham Number--
Graham Net-Net$1.23
Profitability
Earnings Yield-2.46%FCF Yield-1.87%ROE-25.49%ROIC-26.77%Return on Tangible Assets-22.10%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-31.99%
CapEx/Revenue0.00%
CapEx/Depreciation93.51
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.00
Net Debt/EBITDA0.41
Current Ratio19.66Interest Coverage0.00xIncome Quality0.98Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding46049 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.01x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$183.24M
Working Capital$181.91M
Invested Capital$182.76M
Intangibles/Assets0.00%